[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 26, 2016

New Horizons in Allergen Immunotherapy

Author Affiliations
  • 1Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(16):1711-1712. doi:10.1001/jama.2016.4078

Even though allergen immunotherapy has been studied for more than a century, a great deal remains unknown about this commonly used treatment.1 Immunotherapy, which is of benefit to the majority of appropriately selected patients, still largely relies on the injection of relatively crude allergen extracts, often involving doses that have not been rigorously studied.2 The renewed interest in the study of immunotherapy over the past decade is encouraging and has resulted in important advances, including development of more refined allergens, assessment of different routes of delivery, and studies on the treatment of food allergy.